Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Einfacher Volltextzugriff von (fast) überall
Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...
Open Access
    Datensatz exportieren als...
  • BibTeX
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)
Annals of oncology, 2015-09, Vol.26 (9), p.1877-1883
2015
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
Annals of oncology, 2019-03, Vol.30 (3), p.447-455
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study
Annals of oncology, 2015-09, Vol.26 (9), p.1883-1889
2015
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study
Annals of oncology, 2018-10, Vol.29, p.viii740-viii740
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with multiple brain metastases
Annals of oncology, 2019-04, Vol.30, p.ii69-ii70
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial
Annals of oncology, 2023-10, Vol.34 (10), p.907-919
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Dynamic changes of patelet-to-lymphocyte ratio predict efficacy of PD-1/PD-L1 inhibitors in NSCLC
Annals of oncology, 2019-04, Vol.30, p.ii61-ii61
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Previous exposure to bevacizumab indicated inferior benefits from PD-1/PD-L1 inhibitors in nonsquamous NSCLC
Annals of oncology, 2019-04, Vol.30, p.ii62-ii62
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Discrepancy of tumor neoantigen burden between primary lesions and matched metastases in lung cancer
Annals of oncology, 2018-10, Vol.29, p.viii403-viii403
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Genomic landscape and its correlation with TMB, CD8 TILs and PD-L1 expression in Chinese lung squamous cell carcinoma
Annals of oncology, 2018-10, Vol.29, p.viii483-viii483
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials
Annals of oncology, 2016-11, Vol.27 (11), p.2103-2110
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
Annals of oncology, 2020-02, Vol.31 (2), p.191-201
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
539P Biomarker analysis of IBI110 (anti-LAG-3 mAb) in combination with sintilimab (anti-PD-1 mAb) and chemotherapy as 1L treatment for advanced squamous non-small cell lung cancer (sqNSCLC)
Annals of oncology, 2023-11, Vol.34, p.S1680
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy
Annals of oncology, 2013-11, Vol.24 (11), p.2881-2886
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)
Annals of oncology, 2013-06, Vol.24 (6), p.1615-1622
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A phase III, randomized, open-label, multicenter study of SHR-1210 (anti-PD-1 antibody) in combination with pemetrexed and carboplatin as first line therapy in subjects with advanced/metastatic non-squamous non-small cell lung cancer
Annals of oncology, 2018-10, Vol.29, p.viii545-viii545
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG–0803)
Annals of oncology, 2013-04, Vol.24 (4), p.993-999
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
ROS1 fusions in Chinese patients with non-small-cell lung cancer
Annals of oncology, 2013-07, Vol.24 (7), p.1822-1827
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Role of industry funders in oncology RCTs published in high-impact journals and its association with trial conclusions and time to publication
Annals of oncology, 2018-10, Vol.29 (10), p.2129-2134
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
LBA56 ORIENT-12: Sintilimab plus gemcitabine and platinum (GP) as first-line (1L) treatment for locally advanced or metastatic squamous non-small-cell lung cancer (sqNSCLC)
Annals of oncology, 2020-09, Vol.31, p.S1186-S1186
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
RETRACTED: ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)
Annals of oncology, 2020-12, Vol.31, p.S1428-S1428
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Retraction notice to “30MO ORIENT-3: A randomized, open-label, phase III study of sintilimab versus docetaxel in previously treated advanced/metastatic squamous non-small cell lung cancer (sqNSCLC)”: [Annals of Oncology Volume 31, Supplement 7, December 2020, Page S1428]
Annals of oncology, 2021-04, Vol.32 (4), p.576-576
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A study evaluating the different treatment modalities for EGFR mutation positive advanced NSCLC patients that acquire c-MET amplification after EGFR TKI therapy resistant
Annals of oncology, 2019-04, Vol.30, p.ii51-ii51
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis
Annals of oncology, 2018-05, Vol.29 (5), p.1329-1330
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Primary results of ALESIA: A randomised, phase III, open-label study of alectinib vs crizotinib in Asian patients with treatment-naïve ALK+ advanced NSCLC
Annals of oncology, 2018-10, Vol.29, p.viii740-viii740
2018
Volltextzugriff (PDF)
1 – 25 von 517
Suche als RSS-Feed
Aktive Filter
Zeitschrift / SerieAnnals Of Oncology
Suchergebnisse filtern
Filter anzeigen